A CLINICAL RESEARCH CAREER WORKING SPONSOR-SIDE, CRO-SIDE TO SITE-SIDE AT PARATUS CLINICAL
With
Megan Morrison,
Chief Executive Officer
Paratus Clinical
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Melbourne | December 2025
In July 2025, Paratus Clinical, a Australian provider of dedicated clinical trial services, announced the appointment of Megan Morrison as its new Chief Executive Officer, at the same time as a significant milestone as the company celebrating over a decade of impact in the clinical research space. Paratus now operates a network of five purpose-built, research-only clinics along Australia’s eastern seaboard.
Megan Morrison as the Chief Executive Officer of Paratus Clinical, brings more than 24 years of experience in the clinical research industry. She has held senior leadership roles across sponsor organisations, CROs and clinical sites, giving her a uniquely comprehensive perspective on the challenges and opportunities across the drug development ecosystem.
With a background in pharmacology and a Master of Business Administration, Megan combines scientific expertise with commercial and operational acumen. She is committed to advancing Australia’s role in global clinical research by expanding access to innovative studies, strengthening partnerships with sponsors, and ensuring that high-quality outcomes are delivered for both patients and partners.
In this interview with Australian Health Journal she talks about her career journey, current trends in the industry as well as recent projects. Megan also shares her career advice on being curious, in a frequently changing environment such as clinical research, for the benefit of sponsors getting new therapies to market.
Source: Adapted from Paratus Clinical media releases and website
You Might also like
-
Shaping Health, Advancing Nursing through training, upskilling & scholarships
The Chief Executive Officer of Australian College of Nursing, Adjunct Professor Kylie Ward FACN spoke in depth with Australian Health Journal about:
The key recommendations in ACN’s pre-budget submission to Federal Government
The impact of legislation requiring a Registered Nurse (RN) at every residential aged care facility from 1st July 2023
Why scholarships in nursing leadership are important
Why ACN has recommended the Government fund 200 Pacific nurses in 15 nations for the online ACN postgraduate certification
The need for a multi-pronged approach that includes skilled migration in rebuilding the nursing workforceIn the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
-
Awareness, diagnosis and treatment of Congenital Hypothyroidism
Australian Health Journal spoke to Associate Professor MIchelle Jack about congenital hypothyroidism and newborn screening and her concerns in the varying thresholds for across different states in Australia. Despite the existence of newborn screening programs since the 1970s, there is still controversy surrounding the appropriate screening levels. Congenital hypothyroidism, affecting about one in 3500 infants, can lead to severe intellectual and physical impairment if not diagnosed early. The condition is mainly caused by the thyroid gland’s failure to develop properly, resulting in insufficient thyroid hormone production.
-
Trends report identifies prototyping targets for breakthroughs in digital and hybrid futures
Vishaal Kishore, a Professor of Innovation and Public Policy at RMIT in Melbourne, serves as the Executive Chair of the RMIT-Cisco Health Transformation Lab and RMIT’s Director of Impact. Led by the RMIT-Cisco Health Transformation Lab, the National Industry Innovation Network (NIIN) Health Alliance combines the best minds, technologists, industry capabilities and academic resources to solve pressing industry and social challenges through technology-driven innovation. The NIIN aims to pool insights and expertise to address national health challenges, marking its first vertical focus on health.